A postdoctoral position is available to study the role of the T cells in combating hematologic malignancies. This work is translational in nature, including evaluation of the immunological effects cellular immunotherapies (tumor infiltrating lymphocytes, TCRs, or CAR T cells) and pre-clinical investigation into the precursor frequency, phenotype, and gene expression of T cells specific for tumor associated antigens or neoantigens. Major effort will include the development of in vivo models to inform the design early phase clinical trials testing the adoptive transfer of tumor antigen specific T cells.
The successful candidate will be working in an energetic and highly-translational environment at a NCI-designated Comprehensive Cancer with research programs in Immunology, Cancer Biology and Evolution, Chemical Biology and Molecular Medicine. Moffitt Cancer Center has a 211 bed cancer hospital dedicated to clinical research, including vaccine and immunotherapy of cancer, and has state-of-the-art core facilities for cell therapy, flow cytometry, proteomics, molecular genomics, and in vivo animal imaging.
Candidates must have a Ph.D. or M.D. degree and have expertise in cell biology, immunology, molecular biology and will be familiar with routine cell culture, immune assays, western blotting, flow cytometry, and mouse models.
Interested and qualified applicants must submit an online application by visiting https://moffitt.org/careers-education/ and enter 20672 in the keyword search field. |
|
